LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 206 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.46 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $796,000 | -88.9% | 8,000 | -86.7% | 0.03% | -98.0% |
| Q2 2016 | $7,156,000 | -0.3% | 60,000 | -10.4% | 1.32% | +9.5% |
| Q1 2016 | $7,175,000 | -1.2% | 67,000 | 0.0% | 1.21% | +14.8% |
| Q4 2015 | $7,264,000 | +26.6% | 67,000 | 0.0% | 1.05% | +36.6% |
| Q3 2015 | $5,739,000 | +191.5% | 67,000 | +81.1% | 0.77% | +233.3% |
| Q4 2014 | $1,969,000 | +186.2% | 37,000 | +152.6% | 0.23% | +159.6% |
| Q3 2014 | $688,000 | – | 14,647 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |